Revolutionizing Women's Health: Diagnostics
Haemetrics is redefining diagnostics with intelligent, AI-driven platforms that close critical gaps in global healthcare. Our integrated ecosystem—rapid point-of-care testing paired with continuous wearable monitoring—delivers faster, more affordable, and more comprehensive insights than traditional labs.
About Us
We thrive to serve underserved patients and clinicians who need fast, actionable diagnostics but are held back by cost, delays, and complexity. While traditional tests demand days, costly equipment, and specialized staff, often measuring one marker at a time. Haemetrics delivers comprehensive results under an hour at the point of care, with continuous monitoring between visits.
Headquartered in Phoenix, AZ (USA) and Singapore, Haemetrics is positioned for global scale, driving a future where reproductive health decisions are faster, smarter, and more accessible, unlocking profound impact for millions of women and their families.
Vision
To ensure every woman gains swift, equitable access to essential healthcare through innovative, on-site testing that provides reliable data precisely when it matters most
Mission
To eliminate barriers in women’s health diagnostics, making blood tests simple, affordable, and rapid at clinics. By bridging the gap between testing and treatment, Haemetrics equips healthcare professionals, specialists, and diagnostic labs with tools for informed, timely decisions that enhance patient outcomes.
Innovation
Our flagship tabletop POCT device measures key reproductive hormones with lab-grade precision, offering clinics full autonomy, cost efficiencies, and seamless integration into existing workflows. Targeting frontline healthcare providers, this solution addresses critical unmet needs in women’s health, from fertility assessments to endocrine monitoring.
Early Detection
Catch problems early — before they become serious
Early Diagnosis
Real-time results → Immediate decisions and quicker care.
Personalized Profile
Tailored care powered by rapid diagnostic profile
Healthcare Equity
Advanced diagnostics — now accessible to every woman
Technology
Technology
Rapid Diagnostic Platform
Our flagship diagnostic platform integrates advanced biosensing technologies with proprietary AI algorithms to enable:
- Rapid Multi-Analyte Testing: Simultaneous analysis of multiple biomarkers from a single sample (blood, saliva, urine), eliminating the need for repeated testing
- Intelligent Diagnostics: Real-time AI-powered interpretation that connects patterns across analytes for enhanced diagnostic accuracy
- Accessible Operation: Intuitive interfaces requiring minimal technical training, making sophisticated diagnostics available beyond centralized laboratories
- Early Detection Focus: Speed and comprehensiveness designed specifically to catch conditions earlier, when intervention is most effective
AI-Powered Wearable Technology
Building on our diagnostic platform, Haemetrics is developing next-generation wearable devices that extend diagnostic intelligence into continuous health monitoring:
- Real-Time Biomarker Monitoring: Non-invasive or minimally invasive sensors that track key health indicators continuously throughout daily life
- Predictive Health Analytics: Advanced machine learning algorithms that identify subtle patterns and predict potential health events before symptoms emerge
- Seamless Clinical Integration: Wearable data that feeds directly into our diagnostic platform, creating a complete picture of patient health over time
- Personalized Baselines: AI systems that learn individual health patterns to detect meaningful deviations specific to each user
Integrated AI Technology Platform
Our comprehensive technology stack unifies point-of-care diagnostics and continuous monitoring:
- Cross-Platform Intelligence: Machine learning models that synthesize insights from both rapid diagnostic tests and continuous wearable data
- Longitudinal Health Tracking: Systems that track biomarker trends over time, enabling early intervention before acute episodes
- Clinical Decision Support: AI-powered recommendations that help healthcare providers make faster, more informed treatment decisions
- Remote Patient Monitoring: Capabilities that extend clinical care beyond the hospital or clinic into patients’ homes and daily lives
- Data Security & Privacy: Enterprise-grade protection ensuring patient data remains secure across all platforms
How It Works
Market Differentiation
Haemetrics challenges the incumbent model where diagnostic delays, single-analyte testing, and episodic care serve business models rather than patients. Our integrated technology platform enables:
Results in minutes instead of days, with continuous monitoring between tests
Multiple biomarkers from one sample, plus continuous tracking of key indicators
Point-of-care capability and home-based monitoring instead of centralized lab dependency
AI-enhanced interpretation that learns from both diagnostic tests and continuous data streams
Early detection through pattern recognition across time, enabling intervention before crisis
Cost structures that expand access instead of limiting it
Portfolio
Portfolio
Rapid Diagnostic Testing
Our initial product line targets high-impact applications in protein-based diagnostics:
- Hormonal Screening Panels: Comprehensive endocrine profiling for metabolic, reproductive, and thyroid health
- Cancer Biomarker Screening: Multi-marker panels for early detection and monitoring of oncological conditions
- Metabolic Health Assessment: Integrated panels for diabetes, cardiovascular, and metabolic syndrome screening
Wearable Health Monitoring
Our wearable technology roadmap focuses on continuous monitoring for chronic disease management and prevention:
- Metabolic Monitoring Wearables: Continuous tracking of glucose, lactate, and other metabolic indicators for diabetes and metabolic health
- Cardiovascular Health Devices: Real-time monitoring of cardiac biomarkers and physiological parameters for heart health
- Inflammatory Marker Tracking: Wearable sensors that detect early signs of inflammation for chronic disease management
- Hormonal Health Monitoring: Continuous tracking of key hormones for reproductive health, menopause management, and endocrine disorders
Leadership
Navin Govind
Navin is Co-founder and President of Haemetrics, a healthtech company focused on cardio‑renal‑metabolic solutions. An experienced serial entrepreneur, CEO of Aventyn and venture partner at Evidence Ventures, Navin advises startups, holds patents, and has published research. Navin integrates technology and medical devices to improve clinical outcomes worldwide. At K‑Labs, he drives AI initiatives to reduce chronic disease and enhance care. He advocates for science-based digital health standards and sustainable, equitable healthcare policies.
Satya Govind
Satya is Founder of Haemetrics, a global healthtech company advancing clinically validated solutions for women’s health in reproductive health through rapid diagnostics. As an experienced life science professional in quality, regulatory affairs, compliance, and innovation, he has held key leadership roles at major multinationals. Satya leverages scientific and technological expertise to drive AI-powered, affordable and high-quality patentable diagnostic innovations.
Deepthi Mohan
Deepthi is an aspiring biomolecular scientist with several years of experience in molecular diagnostics and point-of-care testing technologies. She specializes in DNA analysis, gene-sequencing, gene expression profiling, and translating complex laboratory science into practical clinical applications. Her work focuses on improving diagnostic accuracy and accessibility, with a strong emphasis on women’s reproductive health. Deepthi is committed to advancing evidence-based, technology-driven solutions supporting healthcare professionals and enhanced patient outcomes.
Contact Us
Haemetrics
3110 N Central Avenue
Unit D-153
Phoenix, AZ 85012 USA
navin@evidencevc.com
Haemetrics
6 Raffles Quay
Singapore 048580